Frequent EpCam protein expression in human carcinomas

Philip Went, Alessandro Lugli, Sandra Meier, +4

Human Pathology

Tumor BiologyPathologyTumor SuppressorMedicineCancer Research +2

High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma

Holger Moch, Peter Schraml, Lukas Bubendorf, +6

American Journal Of Pathology

UrologyFunctional GenomicsGenitourinary CancerMedicineDna Microarrays +12

Arterial Neovascularization and Inflammation in Vulnerable Patients

Michael Fleiner, Marco Kummer, Martina Mirlacher, +4

Circulation

Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer

Khawla S. Al‐Kuraya, Peter Schraml, J. Torhorst, +13

Cancer Research

Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials

Michael F. Press, Guido Sauter, Leslie Bernstein, +12

Clinical Cancer Research

High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer

Gilbert Spizzo, Guenther Gastl, Peter Obrist, +17

Breast Cancer Research and Treatment

Node-positive Breast CancerHigh Ep-cam ExpressionBreast OncologyMedicinePathology +8

The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas

Vassil Kaimaktchiev, Luigi Terracciano, Luigi Tornillo, +8

Modern Pathology

Tumor BiologyGastrointestinal AdenocarcinomasGastrointestinal OncologyMedicineGastroenterology +8

Prevalence of KIT Expression in Human Tumors

Philip Went, Stephan Dirnhofer, Marcel Bundi, +8

Journal of Clinical Oncology

HER-2 amplification is highly homogenous in gastric cancer

Andreas H. Marx, Lars Tharun, Johanna Muth, +9

Human Pathology

Tumor BiologyGastrointestinal OncologyMedicinePathologyGastric Cancer +3

Clinical significance of p53 alterations in surgically treated prostate cancers

Thorsten Schlomm, Liv Iwers, Patrick Kirstein, +13

Modern Pathology